← Back to Search

IMB Model-Based Intervention for HIV Prevention

N/A
Recruiting
Led By Steven A John, MPH, PhD
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
17-24 years old
Individuals who self-identify as male (including transgender men) and report any male sexual partners in the past 6 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will test a new intervention to support HIV self-testing and pre-exposure prophylaxis uptake among young men who have sex with men. The intervention will be based on the Information-Motivation-Behavioral Skills model, and will include videos, directories, and other resources. The primary outcome will be HIVST and PrEP uptake, and secondary outcomes will include changes in IMB model indicators.

Who is the study for?
This trial is for young men (17-24 years old) who have sex with men, live in the US, and are at risk for HIV based on CDC criteria but not currently using PrEP. They should be HIV-negative or unsure of their status. Those with serious psychiatric symptoms, suicidal/homicidal tendencies, cognitive impairments, or current PrEP users cannot join.Check my eligibility
What is being tested?
The study tests an intervention based on the Information-Motivation-Behavioral Skills model to encourage HIV self-testing and pre-exposure prophylaxis (PrEP) uptake among participants. It's a randomized controlled trial that includes educational videos and resources about HIV testing and PrEP.See study design
What are the potential side effects?
Since this trial focuses on education and behavior change rather than medication, there are no direct side effects from drugs being tested. However, participants may experience emotional or psychological responses to the content.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 17 and 24 years old.
Select...
I am a man who has had male sexual partners in the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the number of self-reported HIV self-tests

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: IMBExperimental Treatment1 Intervention
Individuals randomized to this arm will receive a behavioral intervention based on the Information-Motivation-Behavior (IMB) model designed to increase HIV self-testing, among other protective behaviors.
Group II: No InterventionActive Control1 Intervention
Individuals randomized to this arm will receive no intervention.

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
610 Previous Clinical Trials
1,162,399 Total Patients Enrolled
Steven A John, MPH, PhDPrincipal InvestigatorMedical College of Wisconsin

Media Library

IMB Clinical Trial Eligibility Overview. Trial Name: NCT04865341 — N/A
HIV/AIDS Research Study Groups: IMB, No Intervention
HIV/AIDS Clinical Trial 2023: IMB Highlights & Side Effects. Trial Name: NCT04865341 — N/A
IMB 2023 Treatment Timeline for Medical Study. Trial Name: NCT04865341 — N/A
~33 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top